(Press-News.org) A collaborative effort between investigators at the Yerkes National Primate Research Center, Emory University School of Medicine and Georgia Institute of Technology has led to the development of a non-invasive method to image simian immunodeficiency virus (SIV) replication in real-time, in vivo.
This approach, which is reported today in Nature Methods' Advance Online Publication, is based on immune positron-emission tomography/computed tomography (PET/CT) and allows for the capture of viral dynamics of SIV, the animal model of human HIV infection. This novel approach has broad application to the study of immunodeficiency virus pathogenesis and drug and vaccine development, as well as to the potential use with human patients to identify viral reservoirs potentially leading to a cure of HIV/AIDS.
Francois Villinger, DVM/PhD, a researcher in the Yerkes Research Center's Microbiology and Immunology division, and Philip Santangelo, PhD, a researcher at Emory University and in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology, spearheaded the study with their respective teams and collaborators at the Emory School of Medicine. Using the nonhuman primate model of human HIV infection, their approach uncovered novel, previously unappreciated sites of viral replication, such as in nasal-tissue and the reproductive organs.
In addition, the methodology was able to capture the previously unappreciated wide variation in viral replication levels within select organs, including sections of the gastrointestinal tract, whether or not the subject was taking antiretroviral therapy (ART). Finally, the methodology allows for repeat analysis of the viral dynamics, for example during acute infection, during ART and upon cessation of ART.
"Before we can hope to eliminate reservoirs of infected HIV cells, we must first identify tissue sites that can possibly serve as these viral reservoirs," says Villinger. "With this new imaging method, we believe we can now do this more effectively in our animal models and that this strategy can translate these non-invasive techniques into investigating the eradication of HIV infection and targeting of virus reservoirs in humans," he continues.
"Use of the technique could lead to a better understanding of viral dynamics in the body, which could help target new generations of therapeutics and diagnostics," adds Santangelo. "This could help us find the regions where the virus is replicating and allow us to focus molecular diagnostics on the areas that are really important," he says.
The imaging tools developed in this study could also have potential applications with other pathogens and disease states, helping researchers understand where the infectious agents reside and how they respond to therapy. The researchers are developing new imaging probes for applying the same technology in humans in the near future.
Yerkes National Primate Research Center: Established in 1930, the Yerkes National Primate Research Center paved the way for what has become the National Institutes of Health-funded National Primate Research Center (NPRC) program. For more than eight decades, the Yerkes Research Center has been dedicated to conducting essential basic science and translational research to advance scientific understanding and to improve human health and well-being. Today, the Yerkes Research Center is one of only eight NPRCs. The center provides leadership, training and resources to foster scientific creativity, collaboration and discoveries, and research at the center is grounded in scientific integrity, expert knowledge, respect for colleagues, an open exchange of ideas and compassionate, quality animal care.
In the fields of microbiology and immunology, infectious diseases, pharmacology and drug discovery, transplantation, neurologic and psychiatric diseases, as well as behavioral, cognitive and developmental neuroscience, Yerkes scientists use innovative experimental models and cutting-edge technologies to explore and test transformative concepts aimed at: preventing and treating viral diseases such as AIDS; designing novel vaccines for infectious diseases such as malaria and tuberculosis; enhancing the potential of organ transplantation and regenerative medicine; discovering new drugs and drug classes through high-throughput screening; defining the basic neurobiology and genetics of social behavior and developing new therapies for disorders such as autism and drug addiction; understanding the biology of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases; and advancing knowledge about the evolutionary links between biology and behavior.
INFORMATION:
Coulter Department of Biomedical Engineering: The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University is the largest biomedical engineering department in the United States, with 38 faculty, 1,400 undergraduate students and 200 graduate students. Operated in a partnership between a leading public engineering school and a highly respected private medical school, the Coulter Department's graduate program is ranked second in the nation by U.S. News & World Report.
A new study of acute lymphoblastic leukemia (ALL), a blood cancer that primarily affects young children, has revealed that the disease has two distinct subtypes, and provides preliminary evidence that about 13 percent of ALL cases may be successfully treated with targeted drugs that have proved highly effective in the treatment of lymphomas in adults.
Usually emerging in children between 2 and 5 years of age, ALL occurs when the proliferation of white blood cells known as lymphocytes spirals out of control. The current standard of care for ALL employs high doses of chemotherapy ...
A process that is too fast to be measured and analysed. Yet a group of international scientists did not lose heart and conceived a sort of highly sophisticated moviola film-editing system, which allowed them to observe - for the first time in a direct manner - an effect underlying high-temperature conductivity. The results of their work have been published in Nature Physics on Monday 9 March 2015.
Superconductors have properties that make them potentially very interesting for technology (examples of application include magnetic levitation trains). The road to a true application ...
Narcoleptics suffer from bouts of sleepiness and sleep attacks, which impair their ability to function in daily life. But the precise cause of narcolepsy has long eluded scientists, and the cure for the devastating neurological disorder afflicting an estimated three million people worldwide -- and one in 3,000 Americans -- remains at bay.
A new study published in Pharmacological Research by the world's leading autoimmune disease expert, Tel Aviv University's Prof. Yehuda Shoenfeld, finds that narcolepsy bears the trademarks of a classic autoimmune disorder and should ...
BOSTON, MA - Healthcare spending is at an all-time high in the U.S., yet young African-American men see little benefit, according to Boston Medical Center (BMC) researchers' Viewpoint commentary published in the current issue of the Journal of the American Medical Association (JAMA).
The researchers note that black men have a life expectancy nearly five years less than white men. While heart disease and cancer contribute to this decreased life expectancy, homicide also plays a large role. From ages 1 to 14, homicide is either the second or third leading cause of death ...
The extraordinary promise of quantum information processing -- solving problems that classical computers can't, perfectly secure communication -- depends on a phenomenon called "entanglement," in which the physical states of different quantum particles become interrelated. But entanglement is very fragile, and the difficulty of preserving it is a major obstacle to developing practical quantum information systems.
In a series of papers since 2008, members of the Optical and Quantum Communications Group at MIT's Research Laboratory of Electronics have argued that optical ...
LINCOLN, NE - Turfgrass professionals have created seed mixes specifically blended to ensure disease and insect resistance, water use efficiency, and tolerance to traffic. For example, a commonly used mixture of kentucky bluegrass (KBG) and perennial ryegrass (PRG) seed offers advantages such as rapid germination and establishment and provides turf cover that can compete with weeds. A new study shows how initial composition of KBG:PRG in the seed mixture affects species composition over multiple years in the Midwest, and offers recommendations about seeding ratios for optimal ...
ROCHESTER, Minn. -- Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies. Still, the drug is commonly being used in this population, Mayo Clinic Children's Center and co-authors say in ...
LAWRENCE -- Libya hasn't been terribly hospitable for scientific research lately.
Since the 2011 toppling of Muammar Gaddafi, fighters tied to various tribes, regions and religious factions have sewn chaos across that nation. Most recently, ISIS militants in Libya committed mass beheadings that triggered retaliatory bombings by neighboring Egypt.
"Currently, it is obviously very dangerous to be a Western scientist in Libya," said Christopher Beard, Distinguished Foundation Professor of Ecology and Evolutionary Biology at the University of Kansas. "Even Libyan citizens ...
Lots of potentially useful medical information is getting lost. McGill researchers discovered this when they looked into the lack of reporting of information from "stalled drug" trials in cancer, cardiovascular and neurological diseases.
"Stalled drugs" are drugs that fail to make it to the market either because they prove to be ineffective or unsafe or both. Because only one in ten of the drugs that goes into human testing actually gets licensed, most of the information collected in developing new drugs is currently being lost. This is despite the fact that this information ...
In a study published in the current online issue of JAMA Psychiatry, an international team of scientists, led by researchers at the University of California, San Diego School of Medicine, report finding a highly accurate blood-based measure that could lead to development of a clinical test for autism spectrum disorder (ASD) risk in males as young as one to two years old. The test could be done in community pediatric settings. The degree of accuracy, they said, out performs other behavioral and genetic screens for infants and toddlers with ASD described in literature.
The ...
